Product image of Klimicin (Clindamycin Phosphate) supplied by GNH India

Klimicin

Active Ingredient:
Clindamycin Phosphate
Origin:
EU

Klimicin (Clindamycin Phosphate)

Clindamycin phosphate, the active ingredient in Klimicin, is a lincosamide antibiotic presented as an injectable solution for intramuscular and intravenous use. It treats a range of bacterial infections, particularly in skin, bone, and intra‑abdominal sites, and is prescribed for patients requiring parenteral therapy.

GNH India supplies Klimicin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Klimicin, a lincosamide antibiotic, is used to treat bacterial infections affecting various tissues and organ systems.

  • Skin and soft tissue infections: reduces bacterial load and promotes healing of cellulitis, abscesses, and wound infections.
  • Bone and joint infections: eradicates pathogens in osteomyelitis and septic arthritis, supporting recovery of bone integrity.
  • Intra‑abdominal infections: combats mixed anaerobic and aerobic bacteria in peritonitis and intra‑abdominal abscesses.
  • Other bacterial infections: provides coverage for susceptible Gram‑positive and anaerobic organisms in diverse clinical scenarios.

How It Works

  • Clindamycin phosphate is a prodrug that, after conversion to clindamycin, binds to the 50S subunit of bacterial ribosomes. This binding blocks the translocation step of protein synthesis, preventing peptide chain elongation and thereby inhibiting bacterial growth. The action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations.

Side Effects

Adverse reactions to Klimicin vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal discomfort.
  • Diarrhea: loose stools, occasionally watery.
  • Injection site pain: local tenderness or erythema.
  • Rash: mild skin eruptions or itching.

Serious or Rare Side Effects

  • Clostridioides difficile colitis: severe diarrhea with possible pseudomembranous colitis.
  • Anaphylaxis: acute hypersensitivity with respiratory distress and hypotension.
  • Hepatotoxicity: elevated liver enzymes indicating liver injury.

Precautions & Warnings

When prescribing Klimicin, clinicians should consider several safety precautions.

  • Renal impairment: adjust dosing and monitor renal function.
  • Hepatic disease: use cautiously and monitor liver enzymes.
  • Pregnancy: safety not established; weigh benefits against potential risks.
  • Concomitant antibiotics: avoid use with macrolides that may increase toxicity.
  • Allergic history: assess for prior hypersensitivity to lincosamides.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Klimicin may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Erythromycin: increased risk of hepatotoxicity due to shared metabolism.
  • Neuromuscular blockers: potentiation of blockade leading to respiratory depression.
  • CYP3A4 inhibitors (e.g., ketoconazole): heightened clindamycin levels and toxicity.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible enhancement of anticoagulant effect; monitor INR.
  • Metronidazole: additive risk of gastrointestinal upset.
  • Oral contraceptives: may reduce efficacy; advise alternative contraception.

Frequently Asked Questions

Klimicin is a prescription injectable antibiotic indicated for the treatment of serious bacterial infections such as skin and soft‑tissue infections, bone and joint infections, intra‑abdominal infections, and other infections caused by susceptible Gram‑positive and anaerobic organisms.

Clindamycin phosphate is converted in the body to clindamycin, which binds to the 50S ribosomal subunit of bacteria. This binding blocks the translocation step of protein synthesis, halting peptide chain elongation and inhibiting bacterial growth.

The appropriate dose of Klimicin is determined by the prescribing clinician based on the type and severity of the infection, patient weight, renal and hepatic function, and other individual factors. No fixed regimen is provided here.

Safety of Klimicin in pregnancy and lactation has not been established. Clinicians must weigh the potential benefits against possible risks to the fetus or infant and consider alternative therapies when appropriate.

To order Klimicin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Klimicin (clindamycin) belongs to the lincosamide class and is effective against many Gram‑positive and anaerobic bacteria, whereas vancomycin is a glycopeptide primarily targeting resistant Gram‑positive organisms. Choice depends on the pathogen profile, site of infection, resistance patterns and patient-specific factors.

Klimicin should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen. Keep the vial in its original packaging and avoid exposing it to excessive heat or moisture.

Klimicin is administered by a healthcare professional via intramuscular or intravenous injection. The exact route, infusion rate, and duration are determined by the prescriber based on the clinical situation.

The most serious risks include Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, and potential liver injury. Patients should be monitored for persistent diarrhea, rash, respiratory distress, or signs of hepatic dysfunction.

Klimicin should be avoided in individuals with a known hypersensitivity to clindamycin, lincosamides, or any component of the formulation. Caution is also advised for patients with severe hepatic impairment or a history of severe colitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clindamycin Phosphate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT